サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526233

持続的腎代替療法（CRRT）の世界市場

Continuous Renal Replacement Therapy (CRRT)

出版日
ページ情報
英文 216 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
持続的腎代替療法（CRRT）の世界市場
出版日: 2024年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 216 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

持続的腎代替療法（CRRT）の世界市場は2030年までに23億米ドルに達する見込み

2023年に15億米ドルと推定される持続的腎代替療法（CRRT）の世界市場は、分析期間2023-2030年にCAGR 5.9%で成長し、2030年には23億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである透析液・交換液は、CAGR 5.4%を記録し、分析期間終了時には15億米ドルに達すると予測されます。CRRTディスポーザブル＆システム分野の成長率は、分析期間のCAGRで6.9％と推定されます。

米国市場は推定3億7,050万米ドル、中国はCAGR 8.3％で成長予測

米国の持続的腎代替療法（CRRT）市場は、2023年に3億7,050万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 8.3%で推移し、2030年には3億1,660万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5％と4.7％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の持続的腎代替療法（CRRT）市場- 主要動向と促進要因まとめ

持続的腎代替療法（CRRT）は、主に集中治療室（ICU）で腎不全の急性疾患患者、特に血行動態が不安定な患者を治療するために使用される透析の一形態です。数時間かけて急速に溶質と水分を除去する間歇的血液透析とは異なり、CRRTは1日24時間かけて行われ、腎臓本来の機能をより忠実に模倣しています。この穏やかで継続的なプロセスは、老廃物や余分な水分を徐々に除去できるため、体液の状態が変動し、腎機能が低下している患者さんの安定化に役立ちます。CRRTは、体液過多の管理、安定した血行動態の維持、血液化学的コントロールにおいて特に有益であり、これは従来の透析に伴う急激な変化に耐えられない重症患者にとって極めて重要です。

CRRTの背後にある技術は、安全性、効率性、他のICU療法との統合性を高めることを目的として大きく進歩してきました。最新のCRRT装置は、精密な体液バランス制御、洗練されたユーザーインターフェイス、血液凝固や低血圧などの合併症の予防に役立つ統合された安全機能を備えています。このような改良により、世界中のICUでCRRTの導入が進んだだけでなく、腎機能補助だけでなく、敗血症や多臓器不全における血液浄化技術にも応用が広がっています。さらに、現在進行中の膜技術と透析液の技術革新は、電解質不均衡やその他の副作用のリスクを最小限に抑えながら、溶質の除去効率を高めるように設計されています。ICUにおけるCRRTと他のモニタリング機器や治療機器との統合は、クリティカルケアへの包括的なアプローチであり、複雑な症例を管理するための多面的な戦略を支えています。

持続的腎代替療法市場の成長は、急性腎障害（AKI）の発生率の増加、CRRT技術の進歩、この療法の利点に対する認知度の向上、世界のヘルスケアインフラの拡大など、いくつかの要因によってもたらされます。人口の高齢化と糖尿病、高血圧、慢性腎臓病などの有病率の上昇は、AKIの発生率の上昇に寄与しており、CRRTの需要に拍車をかけています。CRRT装置の効率性と安全性を高める技術の進歩は、この治療をより身近で効果的なものにし、病院全体への幅広い採用を促しています。さらに、ヘルスケアプロバイダーが重症患者を管理するニュアンスをより認識するようになるにつれて、従来の腎代替療法よりもCRRTの利点が重視されるようになり、これが市場の成長を支えています。最後に、特に新興国におけるヘルスケア・インフラの拡充は、CRRTのような先進医療を採用するさらなる機会を提供し、市場全体の成長を支えています。

調査対象企業の例（注目の18社）

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP11315

Global Continuous Renal Replacement Therapy (CRRT) Market to Reach US$2.3 Billion by 2030

The global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the CRRT Disposables & Systems segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$370.5 Million While China is Forecast to Grow at 8.3% CAGR

The Continuous Renal Replacement Therapy (CRRT) market in the U.S. is estimated at US$370.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Continuous Renal Replacement Therapy (CRRT) Market - Key Trends & Drivers Summarized

Continuous Renal Replacement Therapy (CRRT) is a form of dialysis used primarily in the intensive care unit (ICU) to treat acutely ill patients with renal failure, particularly when they are hemodynamically unstable. Unlike intermittent hemodialysis that rapidly removes solutes and fluids over a few hours, CRRT is performed over 24 hours a day, mimicking the kidneys’ natural functions more closely. This gentle and continuous process helps to stabilize patients with fluctuating fluid status and compromised kidney function by allowing for the gradual removal of waste products and excess fluid. CRRT is especially beneficial in managing fluid overload, maintaining stable hemodynamics, and controlling blood chemistry, which is crucial in critically ill patients who may not tolerate the rapid changes associated with conventional dialysis.

The technology behind CRRT has seen significant advancements aimed at enhancing safety, efficiency, and integration with other ICU therapies. Modern CRRT machines offer precise fluid balance control, sophisticated user interfaces, and integrated safety features that help prevent complications such as blood clotting and hypotension. These improvements have not only increased the adoption of CRRT in ICUs around the world but also expanded its applications beyond renal support to include blood purification techniques in sepsis and multi-organ failure. Moreover, ongoing innovations in membrane technology and dialysis solutions are designed to enhance solute removal efficiency while minimizing the risk of electrolyte imbalances and other side effects. The integration of CRRT with other monitoring and therapeutic devices in the ICU represents a comprehensive approach to critical care, supporting a multifaceted strategy for managing complex cases.

The growth in the Continuous Renal Replacement Therapy market is driven by several factors, including an increase in the incidence of acute kidney injury (AKI), advancements in CRRT technology, rising awareness of the therapy’s benefits, and expanding healthcare infrastructure globally. The aging population and higher prevalence of conditions such as diabetes, hypertension, and chronic kidney disease contribute to the rising incidence of AKI, thereby fueling the demand for CRRT. Technological advancements that enhance the efficiency and safety of CRRT machines make this treatment more accessible and effective, encouraging broader adoption across hospitals. Furthermore, as healthcare providers become more aware of the nuances of managing critically ill patients, there is a greater emphasis on the benefits of CRRT over traditional renal replacement therapies, which supports market growth. Lastly, the expansion of healthcare infrastructure, especially in emerging economies, provides additional opportunities for the adoption of advanced medical treatments like CRRT, supporting the overall growth of the market.

Select Competitors (Total 18 Featured) -

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Continuous Renal Replacement Therapy Market Set for a Steady Growth
    • Dialysates & Replacement Fluids Dominate the Market, Disposables to Register the Fastest Growth
    • Continuous Venovenous Hemofiltration (CVVH) Leads the Market, CVVHDF to Exhibit the Fastest Growth
    • Europe and US Hold the Largest Share, China to Witness Fastest Growth
    • Continuous Renal Replacement Therapy (CRRT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Future Endeavors in CRRT
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in Incidence of Acute Kidney Injury to Drive Market Growth
    • Rise in Aging Population, Growing Number of ICU Patients Spurs the Need for CRRT
    • Rising Incidence of Diabetes: A Key Risk Factor for Acute Kidney Failure
    • TABLE 11: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Increasing Incidence of Cardiovascular Disease Drive Market Growth
    • Prevalence of Heart Failure in Select Countries
    • Advancements in CRRT Machines: Designed for Reliable and Safe Treatment
    • Technological Advancements to Bolster Market Growth
    • Development of CRRT System for Pediatric Patients
    • Miniaturization and Wearable Technology Forays into Acute Renal Replacement Domain
    • Reimbursement Scenario
    • Development of New Hemofilters to Propel Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysates & Replacement Fluids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Disposables & Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Continuous Venovenous Hemofiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Continuous Venovenous Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Continuous Venovenous Hemodiafiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Slow Continuous Filtration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Continuous Renal Replacement Therapy (CRRT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030

IV. COMPETITION